Search for: "Bayer Healthcare Pharmaceuticals"
Results 41 - 60
of 318
Sort by Relevance
|
Sort by Date
27 Nov 2015, 8:59 am
The prescription medication is manufactured by Bayer and marketed in the United States by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. [read post]
27 Nov 2015, 8:59 am
The prescription medication is manufactured by Bayer and marketed in the United States by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. [read post]
6 Jul 2015, 1:09 pm
., the two are of serious concern — Omniscan, made by GE Healthcare, and Magnevist, by Bayer HealthCare. [read post]
14 May 2015, 8:52 am
Bayer-Healthcare Pharm., Inc., 2015 WL 293496 (N.D. [read post]
24 Mar 2015, 11:54 am
Most recently, a wrongful death lawsuit was filed against the makers of Xarelto; Bayer Healthcare and Johnson and Johnson’s subsidiary, Janssen. [read post]
16 Mar 2015, 3:10 am
Never too late 33 [week ending Sunday 15 February] –-Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in… [read post]
9 Mar 2015, 12:23 pm
Never too late 33 [week ending Sunday 15 February] –-Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in Europe reviewed | Italian baked… [read post]
6 Mar 2015, 5:00 am
Bayer Healthcare Pharmaceuticals, No. 5:14-cv-00101, 2015 U.S. [read post]
2 Mar 2015, 2:43 pm
Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in Europe reviewed | Italian baked goods’… [read post]
23 Feb 2015, 2:55 am
***** PREVIOUSLY, ON NEVER TOO LATE Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on… [read post]
20 Feb 2015, 6:49 am
Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary currently face nearly 90 product liability lawsuits over their new-generation coagulant, Xarelto. [read post]
16 Feb 2015, 1:44 am
* Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
11 Feb 2015, 12:23 pm
After Naproxen was approved for OTC use in Mexico, a mass-market version of FLANAX was launched in 2001-02.... and Bayer's FLANAXBelmora, a small US pharmaceutical company seeking to introduce Spanish-language packaging to the US OTC market, learned of Mexican FLANAX. [read post]
25 Dec 2014, 8:24 am
However, the joint Xarelto pharmaceutical manufacturers and distributors (Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, and Bayer Healthcare) are pushing back. [read post]
18 Dec 2014, 9:58 am
Over 50 Federal Xarelto Lawsuits Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to at least 50 product liability lawsuits over their new-generation anticoagulant. [read post]
17 Dec 2014, 8:31 am
Xarelto is a new generation anticoagulant developed by Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary in 2011 as a superior alternative to warfarin (Coumadin), the blood thinner used widely since the 1950s for the prevention of strokes. [read post]
4 Dec 2014, 12:48 pm
Over 50 Federal Xarelto Lawsuits Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary are exposed to at least 50 product liability lawsuits over their new-generation anticoagulant. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
30 Oct 2014, 9:51 am
Bayer Healthcare Pharmaceutical, Inc., No. 10–1695, 2013 WL 1289050 (W.D. [read post]
16 Oct 2014, 1:16 pm
Mutual Pharmaceutical Company, Inc. [read post]
